Souhaitez-vous accéder aux communiqués récents ?

Independent Data Monitoring Committee recommended trial stop early due to overwhelming efficacy at pre-planned analysisPhase IIIb clinical development of Airsupra was conducted by Avillion under an...

LONDON, Oct. 01, 2024 (GLOBE NEWSWIRE) -- Kiniksa Pharmaceuticals International, plc (Nasdaq: KNSA) (Kiniksa), a commercial-stage biopharmaceutical company, has teamed up with National Hockey...

Provides updates on BioNTech’s strategy to scale and deploy AI-capabilities across the immunotherapy pipelineHighlights InstaDeep’s new near exascale supercomputer, Kyber, with the aim of enabling...

Hamilton, Bermuda, Sept. 24, 2024 (GLOBE NEWSWIRE) -- Company to host conference call today at 8.30 a.m. ETContinued progress within core activities in RNA delivery, supported by move into new...

NEWARK, Del, Sept. 23, 2024 (GLOBE NEWSWIRE) -- The global bulk-drug compounding market is expected to experience significant growth over the next decade, with sales projected to reach USD 11,887.6...

MAINZ, Germany, September 17, 2024 (GLOBE NEWSWIRE) -- BioNTech SE (Nasdaq: BNTX, “BioNTech”), alongside its artificial intelligence (“AI”) company InstaDeep Ltd. (“InstaDeep”), will host an AI Day,...

LONDON and NEW YORK, Sept. 10, 2024 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (NASDAQ: OKYO), a clinical-stage biopharmaceutical company developing innovative ocular therapies for the treatment of...

Dublin, Sept. 06, 2024 (GLOBE NEWSWIRE) -- The "Cognitive Testing in Clinical Drug Trials: Successful Test Selection and Integration Training Course" conference has been added to ...

LONDON and NEW YORK, Sept. 05, 2024 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (NASDAQ: OKYO), a clinical-stage biopharmaceutical company developing innovative ocular therapies for the treatment of...

Dublin, Sept. 04, 2024 (GLOBE NEWSWIRE) -- The "Pharma Supply Chain & Security World 2025" conference has been added to ResearchAndMarkets.com's offering. The Annual Pharma Supply Chain &...